CDPPB

CDPPB is a drug used in scientific research which acts as a positive allosteric modulator selective for the metabotropic glutamate receptor subtype mGluR₅.^[1][2][3] It has antipsychotic effects in animal models,^[4] and mGluR₅ modulators are under investigation as potential drugs for the treatment of schizophrenia,^[5] as well as other applications.^[6][7]

CDPPB

Identifiers
IUPAC name 3-cyano-N-(1,3-diphenyl-1H-pyrazol-5-yl)benzamide
CAS Number	781652-57-1 Y
PubChem CID	11245456
IUPHAR/BPS	1422
ChemSpider	9420491 N
UNII	Y4F3R8YW3G
CompTox Dashboard (EPA)	DTXSID80459996
ECHA InfoCard	100.222.673
Chemical and physical data
Formula	C23H18N4O
Molar mass	366.424 g·mol−1
3D model (JSmol)	Interactive image
SMILES c3ccccc3-n1nc(-c4ccccc4)cc1NC(=O)c(c2)cccc2C#N
InChI InChI=1S/C23H16N4O/c24-16-17-8-7-11-19(14-17)23(28)25-22-15-21(18-9-3-1-4-10-18)26-27(22)20-12-5-2-6-13-20/h1-15H,(H,25,28) N Key:BKUIZWILNWHFHD-UHFFFAOYSA-N N
NY (what is this?)  (verify)